ONENESS BIOTECH CO., LTD.
合一生技股份有限公司
Get an email when something changes (or just keep it in this browser without an email).
2008Founded
NT$4.8BPaid-in capital
1Plants
6Certifications
1Patents
NT$100–500MRevenue band
- Unified Business No.
- 29108260
- Industry
- Pharmaceuticals & Medicinal Chemicals (273)
- Main products
- Pharmaceuticals & medicinal chemicals (276)
- Location
- 35 F., No. 66, Sec. 1, Zhongxiao W. Rd., Zhongzheng Dist., Taipei City 100507, Taiwan (R.O.C.)
Pingtung County (1,669) · Nanzhou Township (16) - Listing
- Listed (TPEx) (890) 4743
- Organisation type
- Company Limited by Shares
- Founded
- 2008-06-02
- Paid-in capital
- NT$ 4,805,334,860
- Representative
- Kuo Hsien-shou
- Phone
- 02-27031098
- Website
- https://onenessbio.com/
- Exporter
- Yes — registered with the Trade Administration
- Annual revenue band
- NT$100–500M
- Ownership
- Family-run (inferred)
- North American market
- FDA 510(k) clearance FDA medical device registration Health Canada medical device licence
- Representative tenure
- In office since 2024-06 (2 yrs); last handover 2024-06
- Growth & profitability
- Revenue 2026-09 YoY -18.5%, year-to-date +12.6%
Gross margin 42%, operating margin -519.5%, net margin 128.9% (2026-Q2 YTD) - Compliance record
- Environmental penalties: 2 case(s) in 5 years, latest 2025-11-07, fines NT$ 66,000 (industrial waste)
Certifications 6
- ISO 45001 (962)Official registry Valid until 2027-08-31 · SGS Taiwan Ltd.
- GMP (261)Self-reported
- ISO 13485 (310)Self-reported
- ISO 17025 (76)Self-reported
- ISO 9001 (4,294)Self-reported
- PIC/S GMP (46)Self-reported
Processes & materials 1
- Biotechnology (664) · Company nameSelf-reported
Patents 1
- 2024 Nucleic acid aptamer targeting lymphocyte activation gene 3 (LAG-3) and use thereof
North American market evidence 4
- FDA 510(k) clearance K261638 2026-06-17
Bonvadis® - FDA 510(k) clearance K251093 2025-06-09
Bonvadis® - FDA medical device registration 3015077448 2023-01-31 – 2026-07-02
Dressing, Wound, Drug - Health Canada medical device licence 193558
Public registers of the US FDA, the FCC and Health Canada, matched on the registered English name. An FDA import refusal is a negative record, but also shows goods actually shipped to the US. The FCC dataset ends in 2021.
Government programs & awards 1
- SBIR (Small Business Innovation Research) program 2015 · Ministry of Economic Affairs Small & Medium Enterprise and Startup Administration
Recent changes 1
- PenaltiesEnvironmental penalties: latest case 2025-11-07; 2 case(s) in 5 years, fines NT$ 66,000
RSS feed · Recent changes at Taiwanese manufacturers →
Similar companies 10
- ORIENT PHARMA CO., LTD. · Taoyuan City Listed (TPEx) NT$1–5B
Shared: Biotechnology, GMP, PIC/S GMP, Other medical devices & supplies manufacturing n.e.c. - CALIWAY BIOPHARMACEUTICALS CO., LTD. · New Taipei City Listed (TWSE) < NT$20M
Shared: Biotechnology, GMP, PIC/S GMP, Western pharmaceutical wholesale - PHYTOHEALTH CORPORATION · Taoyuan City Listed (TWSE) NT$100–500M
Shared: Biotechnology, GMP, PIC/S GMP, Western pharmaceutical wholesale - GENOVIOR BIOTECH CORPORATION · Miaoli County NT$100–500M estimated
Shared: Biotechnology, GMP, PIC/S GMP, Other medical devices & supplies manufacturing n.e.c. - TAIWAN BIOTECH CO., LTD. · Taoyuan City Public company (unlisted) ≥ NT$5B
Shared: Biotechnology, GMP, ISO 13485, PIC/S GMP - SAVIOR LIFETEC CORPORATION TAINAN BRANCH · Tainan City Listed (TPEx) NT$1–5B
Shared: GMP, ISO 17025, PIC/S GMP, Western pharmaceutical wholesale - SHOU CHAN INDUSTRIAL CO., LTD. · Nantou County NT$20–100M estimated
Shared: GMP, PIC/S GMP, Western pharmaceutical wholesale - PET PHARM BIOTECH CO., LTD. · New Taipei City Emerging stock (TPEx) NT$100–500M
Shared: Biotechnology, GMP, PIC/S GMP - KAISER PHARMACEUTICAL CO., LTD. · Tainan City NT$1–5B estimated
Shared: GMP, ISO 17025, PIC/S GMP - SOURIREE BIOTECH & PHARM. CO., LTD. · New Taipei City < NT$20M estimated
Shared: Biotechnology, Chinese herbal medicine wholesale, Western pharmaceutical wholesale
Ranked by overlap in processes and materials, registered business activities, certifications and main products; rarer shared traits weigh more. Dissolved companies are excluded.